about
Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genesFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSACommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicPhase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infectionsCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciCo-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infectionsA Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemiaTigecycline challenge triggers sRNA production in Salmonella enterica serovar TyphimuriumLooking toward basic science for potential drug discovery targets against community-associated MRSAEfficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Tigecycline: a novel broad-spectrum antimicrobial.Methicillin-resistant Staphylococcus aureus in HIV-infected patients.Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapyDetection of Clostridium difficile in retail ground meat products in ManitobaIn vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseWhat is in the pipeline for Gram-negative pathogens?Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI.The evaluation and treatment of complicated skin and skin structure infections.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenoInnocent neonate, resistant staph, and embarrassed staffTigecycline: a critical update.Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureusEmergence and management of drug-resistant enterococcal infections.Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.Newer developments in the treatment of Gram-positive infections.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Vancomycin-resistant enterococcal urinary tract infections.Current state of Clostridium difficile treatment options.The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults.Therapy of Clostridium difficile infection: perspectives on a changing paradigm.Treatment of multidrug-resistant Gram-negative infections in children.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma.
P2860
Q21132445-E7FD77AB-95F8-478B-9808-C392CF8D99DFQ22305769-7C99B9A0-3AD8-43B2-97DF-BBF81850E7DFQ24614464-15DBDE62-2581-4B64-A40A-CC9EBEAC4741Q24672937-8AABC905-7222-4BF4-9F2D-9667C54CD315Q26853465-16A35D6E-D0E0-406F-A8D3-1E42624D1989Q28394377-6F41963A-F23F-4E47-B0D9-22A76D0CCC0AQ28820781-81AD484A-D5FB-4119-8D73-EBCA0E24056EQ31089832-9353C275-CD83-439E-BD5D-ED52EC4FBC00Q33560722-2B8AC300-37E6-4543-A9C6-D73375727D67Q33642184-B835ADB3-5C54-4FB4-B191-89C8C2029EB5Q33754471-E71467C2-1BB7-4BAC-A641-997B624A15C8Q34133346-50E0BE93-9C9C-4ED8-B99A-6C17E86AC183Q34630833-D9F7C6F6-9100-488A-A7BA-90A3AAA97454Q35026548-5E90D6EC-50E6-46EA-B352-7F6BB225854BQ35564841-4AB2A5A4-D369-4A35-9AC2-110D715B640AQ35960920-09DE62CC-DE75-4680-8996-DC0DF30A9FBFQ36029505-1132A5BA-A0BD-46A9-94EC-524FA85299AAQ36064268-E9645D78-1C5F-4C3F-92B9-D4A6F6E80EC7Q36744813-678BE4D8-637F-4A57-AECB-3130BDD39218Q36772071-DE6286B1-2728-4DFF-B60D-EE205322B5B8Q36887811-34B6A495-B55A-44FB-A84D-818457AA789AQ37077619-98833AA5-3A7F-49BD-B88C-4897BE31BAE1Q37091605-5566D68E-0EE6-41BE-8FB2-6CA82D0CD628Q37111836-672CB88A-FDB8-4626-9809-AD8EF5C97479Q37144809-44BEF760-D3B6-4683-BF48-A5AF9E195090Q37192153-F86D424B-A579-4082-BA58-EA366D6D1453Q37233932-5D6E7BEE-72F6-4C42-82D2-1E922A94B293Q37247619-59C16329-8CBF-4D46-B4E6-A64545AE4408Q37291346-E96C5791-65D8-4E84-9D2E-3BEB57B0F3F7Q37413851-0515B987-C5EE-4FBE-BB93-5C5876891DD0Q37608268-2B6FE45D-1F98-46CF-9C82-9E264C1F61F3Q37636151-B8A5ED61-B8F8-406C-B24C-7AA3DF354B03Q37785546-8190B5CF-790B-4B6E-8616-BAAD3BBAA020Q37802885-4D16BC62-D2B3-4829-848F-0282C2DEBB33Q38023283-6639B96D-E436-4922-A965-9E7BE3BA50CBQ38084726-8D6D23FF-59EB-4FBD-90FD-F264C0DD25E9Q38139991-665437C4-EF3B-4636-9E72-6C41F0F645EDQ38185648-EFB205D5-DFAF-4DEF-98B4-68242E5DB615Q38907793-A840150E-6772-476D-BD17-285DE51EECFCQ38920797-FED908AD-F56D-4C43-AEF7-E89E00F76996
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Tigecycline: a critical analysis.
@ast
Tigecycline: a critical analysis.
@en
type
label
Tigecycline: a critical analysis.
@ast
Tigecycline: a critical analysis.
@en
prefLabel
Tigecycline: a critical analysis.
@ast
Tigecycline: a critical analysis.
@en
P356
P1476
Tigecycline: a critical analysis.
@en
P2093
Gary E Stein
William A Craig
P304
P356
10.1086/505494
P407
P577
2006-06-26T00:00:00Z